Latest news with #Bayer®Aspirin
Yahoo
17-04-2025
- Business
- Yahoo
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
The facility's new space enhances the company's Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa., April 16, 2025--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community. The ribbon-cutting ceremony was attended by Bayer leaders, employees, elected officials, and members of the local community to commemorate this exciting moment for Bayer and Pennsylvania's Lebanon County. Bayer's Myerstown site has a rich history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer's Consumer Health network globally, producing brands such as Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, Midol®, and more. "Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before," stated Dave Tomasi, President of Bayer's Consumer Health division in North America. "The expanded facility will further strengthen our commitment to providing safe, effective and high-quality self-care solutions that our consumers and customers can depend on." Bayer's Myerstown facility is set to advance its production capabilities through the integration of modernized technology and streamlined processes, strengthening its ability to reliably deliver science-driven self-care solutions. The new space is designed to move products more efficiently with eight new product packaging lines and automated systems in logistics. With the expansion, Bayer is increasing its ability to swiftly respond to the evolving needs of its consumers and customers. Bayer's commitment to growth extends beyond infrastructure and technology; it is an investment in the future of health and wellness for consumers across North America and the people of Myerstown. Along with expanding its physical footprint, the company is dedicated to digitally upskilling its workforce to ensure that employees and the local community are equipped with the knowledge needed to navigate the modern manufacturing landscape. Bayer also plans to welcome local high school educators to tour its Myerstown facilities and operations to bring back information and insights to their school districts. "We recognize that the key to sustainable growth lies in our people. That's why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers," said Divakar Amin, Vice President & Site Manager of Myerstown. "We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals. Together, we are building a brighter future for Bayer and the communities we serve." As Bayer continues to innovate and empower everyday health, the company remains steadfast in its mission to elevate the quality of life for people around the world through trusted health and nutrition solutions. "Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none," said Michael Sullivan, Senior Vice President of Product Supply for Bayer's Consumer Health division in North America. "We are excited about the positive impact this investment will have as we are paving the way for a healthier future where everyone has access to the products that they need to support their well-being." About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to View source version on Contacts Media Contact: Hannah SchwartzEmail: Cell: 862-783-8442 Sign in to access your portfolio
Yahoo
16-04-2025
- Business
- Yahoo
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
The facility's new space enhances the company's Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa., April 16, 2025--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community. The ribbon-cutting ceremony was attended by Bayer leaders, employees, elected officials, and members of the local community to commemorate this exciting moment for Bayer and Pennsylvania's Lebanon County. Bayer's Myerstown site has a rich history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer's Consumer Health network globally, producing brands such as Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, Midol®, and more. "Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before," stated Dave Tomasi, President of Bayer's Consumer Health division in North America. "The expanded facility will further strengthen our commitment to providing safe, effective and high-quality self-care solutions that our consumers and customers can depend on." Bayer's Myerstown facility is set to advance its production capabilities through the integration of modernized technology and streamlined processes, strengthening its ability to reliably deliver science-driven self-care solutions. The new space is designed to move products more efficiently with eight new product packaging lines and automated systems in logistics. With the expansion, Bayer is increasing its ability to swiftly respond to the evolving needs of its consumers and customers. Bayer's commitment to growth extends beyond infrastructure and technology; it is an investment in the future of health and wellness for consumers across North America and the people of Myerstown. Along with expanding its physical footprint, the company is dedicated to digitally upskilling its workforce to ensure that employees and the local community are equipped with the knowledge needed to navigate the modern manufacturing landscape. Bayer also plans to welcome local high school educators to tour its Myerstown facilities and operations to bring back information and insights to their school districts. "We recognize that the key to sustainable growth lies in our people. That's why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers," said Divakar Amin, Vice President & Site Manager of Myerstown. "We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals. Together, we are building a brighter future for Bayer and the communities we serve." As Bayer continues to innovate and empower everyday health, the company remains steadfast in its mission to elevate the quality of life for people around the world through trusted health and nutrition solutions. "Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none," said Michael Sullivan, Senior Vice President of Product Supply for Bayer's Consumer Health division in North America. "We are excited about the positive impact this investment will have as we are paving the way for a healthier future where everyone has access to the products that they need to support their well-being." About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to View source version on Contacts Media Contact: Hannah SchwartzEmail: Cell: 862-783-8442
Yahoo
18-02-2025
- Health
- Yahoo
Bayer® Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to "See Their Risks"
This February, Bayer® Aspirin Teamed Up with Acclaimed Artist, Jason Naylor, to Raise Awareness for Heart Health. WHIPPANY, N.J., February 18, 2025--(BUSINESS WIRE)--In the United States alone, 104 million people are at risk of cardiovascular disease, and in a study of those that experienced a heart attack at age 50 or younger, half were not previously seen as high risk. This February, Bayer® Aspirin is marking Heart Health Month with a new initiative to raise awareness and education about cardiovascular risk factors — especially among those who may dismiss the connection between age and heart health — and empower people to take proactive steps toward protecting their heart health by speaking with their healthcare provider about their risk factors. Many people may dismiss risks to their heart health, believing they're not at risk because they feel fine, lack a family history, or have no obvious risk factors. However, the prevalence of cardiovascular disease rises significantly with age, affecting 40 percent of people aged 40-59, 70-75 percent of those aged 60-79, and 79-86 percent of individuals aged 80 and older.1 Bayer® Aspirin is encouraging everyone to take the simple, 2-minute Bayer® Aspirin Heart Health Risk Assessment at to gain a clearer picture of their heart health risk factors and how they can take action to protect their heart, starting with having a proactive conversation with their healthcare provider.* "Heart disease affects millions of people, many of whom are unaware of their risk," said Sistine Jarvis, Director of U.S. Medical Affairs, Bayer Consumer Health. "We're committed to raising awareness and to providing education to help people make informed decisions about their health together with their healthcare provider. This Heart Health Month, and every month, we're encouraging everyone to check in on their heart health because the more you know, the more you can do to protect yourself and your loved ones." A recent study2 also revealed that heart disease can happen across all age groups. In fact, the difference in prevalence between older and younger generations is surprisingly narrow — Baby Boomers report a 23 percent prevalence, Gen X-ers 17 percent, Millennials 13 percent, and Gen Z-ers 15 percent. With 15 percent of Gen Z-ers potentially living with cardiac conditions, approximately 1 in 6 are at risk. In response, Bayer® Aspirin developed its assessment tool to provide an accessible option for heart health education, while also encouraging people to take the first step in understanding their personal heart health risk factors. Limited-Edition Collaboration with Artist Jason Naylor To further raise awareness about heart health, Bayer® Aspirin is partnering with acclaimed artist Jason Naylor, known for his vibrant heart-themed designs, to create a limited-edition crewneck sweatshirt featuring a spin on his signature "OPN Heart" design. This unique piece, which will be given away via a social sweepstakes, is designed to serve as a reminder for people to take care of their hearts and "See Your Risks."** "Health has always been important to me — emotional, physical, mental, it's all tied together," said Naylor. "My mission of spreading love and kindness to the world relies on my own personal ability to feel my best. OPN Heart was created as an icon of love, both for self and for others. It serves as a reminder that the more love we give, the more we will have. Without taking care of my heart health, I will not be able to spread love the way I want. I'm excited to partner with Bayer® Aspirin and use my OPN Heart design to focus this month on reminding everyone to take care of their hearts, in every way." For more information on the Bayer® Aspirin Heart Health Month initiative and to learn more about your cardiovascular risk factors, visit And follow along on Bayer® Aspirin social channels (Instagram: @BayerAspirin_US; Facebook: @BayerAspirin). About Bayer® Aspirin Bayer® Aspirin is a trusted leader in providing heart health education. With a long-standing commitment to delivering health for all, Bayer® Aspirin continues to lead the way in empowering individuals with the knowledge and resources needed to make informed decisions about their cardiovascular well-being together with their healthcare providers. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to *Does not replace an assessment by a qualified healthcare professional. Always talk to your doctor or healthcare professional about your heart health. ** Bayer® Aspirin launched a comment-to-win social sweepstakes, which select individuals will be rewarded with the Jason Naylor-designed sweatshirt. To enter the sweepstakes, consumers will be asked to tag a friend in the post comments that they want to encourage to take the Bayer® Aspirin Heart Health Risk Assessment, using #Sweepstakes. Offer valid Feb. 1 to Feb. 28 at 11pm ET. Must be at least 18 years old or age of majority to enter. Open to continental US residents only. All winners will be notified no later than March 12. For official rules, check the link in our bio or visit Void where prohibited. 1 Yazdanyar, A., & Newman, A. B. (2009). The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clinics in geriatric medicine, 25(4), 563–vii. 2 Listen to Your Heart: Cardiac Health Has No Age Range | Abbott Newsroom. Published 2023. Accessed January 30, 2025. View source version on Contacts Christin MillerDirector, Strategic Communications, Brand and External PR Consumer Sign in to access your portfolio
